Inozyme Pharma, Inc. (INZY) - Quarterly Balance Statement

Home
INZY
Financials

1.38 (USD) • At close January 15, 2025

Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

	2024 Q3	2024 Q2	2024 Q1	2023 Q4	2023 Q3	2023 Q2	2023 Q1	2022 Q4	2022 Q3	2022 Q2	2022 Q1	2021 Q4	2021 Q3	2021 Q2	2021 Q1	2020 Q4	2020 Q3	2020 Q2	2020 Q1	2019 Q4	2019 Q1
Assets:
Current Assets:
Cash & Cash Equivalents Numbers are in millions	24.575	15.233	20.618	34.588	46.895	40.845	49.024	32.915	44.044	62.62	31.943	23.316	27.229	26.239	16.486	28.04	59.858	50.863	55.637	31.605	-43.163
Short Term Investments Numbers are in millions	107.033	129.29	145.535	154.001	145.547	99.402	81.906	94.951	97.408	88.86	65.83	88.485	98.054	111.225	128.6	119.657	99.644	13.004	18.903	15.527	86.326
Cash and Short Term Investments Numbers are in millions	131.608	144.523	166.153	188.589	192.442	140.247	130.93	127.866	141.452	151.48	97.773	111.801	125.283	137.464	145.086	147.697	159.502	63.867	74.54	47.132	43.163
Net Receivables Numbers are in millions	0	0	0	0.385	0	0	0	0.115	0.096	0.106	0.048	0.062	0.073	0.095	0.122	0.155	0.252	0.082	0.044	0	0
Inventory Numbers are in millions	0	0	0	0	0	0	0	0	0	-0.106	0	-0.062	0	0	0	0	0	0	0	0	0
Other Current Assets Numbers are in millions	9.329	8.439	8.171	7.276	8.414	3.341	3.218	3.412	4.378	2.162	2.762	3.479	5.223	3.403	2.833	3.123	4.189	0.677	0.345	0.224	0
Total Current Assets Numbers are in millions	140.937	152.962	174.324	196.25	200.856	143.588	134.148	131.393	145.926	153.748	100.583	115.342	130.579	140.962	148.041	150.979	163.977	64.66	74.963	47.46	43.163
Non-Current Assets:
Property, Plant & Equipment, Net Numbers are in millions	1.655	1.981	2.308	2.592	2.84	3.169	3.484	3.638	3.931	4.052	4.184	4.436	4.743	4.859	5.029	2.648	2.455	0.846	0.374	0.298	0
Goodwill Numbers are in millions	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Intangible Assets Numbers are in millions	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Goodwill and Intangible Assets Numbers are in millions	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Long Term Investments Numbers are in millions	0	0.311	0.311	0.311	0.311	0.311	0.354	0	0.354	0.379	0.354	88.485	0.354	0.354	2.548	12.199	12.207	0	0	0	0
Tax Assets Numbers are in millions	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Other Non-Current Assets Numbers are in millions	0.769	0.458	0	1.694	1.695	3.861	3.81	4.164	3.81	3.81	3.81	-84.722	2.07	2.084	3.297	3.537	0.354	3.005	0.399	0.186	-43.163
Total Non-Current Assets Numbers are in millions	2.424	2.75	2.619	4.597	4.846	7.341	7.648	7.802	8.095	8.241	8.348	8.199	7.167	7.297	10.874	18.384	15.016	3.851	0.773	0.484	-43.163
Total Assets Numbers are in millions	143.361	155.712	176.943	200.847	205.702	150.929	141.796	139.195	154.021	161.989	108.931	123.541	137.746	148.259	158.915	169.363	178.993	68.511	75.736	47.944	0
Liabilities & Equity:
Current Liabilities:
Account Payables Numbers are in millions	2.21	3.527	2.166	1.166	2.006	2.014	1.815	2.544	1.391	1.339	2.2	2.394	0.626	0.796	1.709	3.069	3.665	1.399	1.569	0.901	0
Short Term Debt Numbers are in millions	5.548	1.918	0.934	1.82	1.772	1.724	1.678	0.816	1.588	1.546	1.504	0.731	1.422	1.382	1.344	0	0	0	0	0	0
Tax Payables Numbers are in millions	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Deferred Revenue Numbers are in millions	0	0	0	0	0	0	0	0	0	3.81	0	0	0	0	0	0	0	0	0	0	0
Other Current Liabilities Numbers are in millions	10.586	10.096	9.306	11.7	8.497	8.343	9.088	11.355	10.154	7.688	8.556	8.508	6.895	4.794	3.779	6.904	6.149	5.328	3.34	2.335	0
Total Current Liabilities Numbers are in millions	18.344	15.541	12.406	14.686	12.275	12.081	12.581	14.715	13.133	10.573	12.26	11.633	8.943	6.972	6.832	9.973	9.814	6.727	4.909	3.236	0
Non-Current Liabilities:
Long Term Debt Numbers are in millions	42.229	45.751	45.701	45.682	33.214	33.255	25.822	5.962	6.108	2.24	2.442	2.64	2.829	3.013	3.194	1.287	0	0	0	0	0
Deferred Revenue Non-Current Numbers are in millions	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Deferred Tax Liabilities Non-Current Numbers are in millions	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Other Non-Current Liabilities Numbers are in millions	0	0	0	0	0	0	0.046	0.124	0	0	0	0	0	0	0	0	1.263	111.803	0	77.927	0
Total Non-Current Liabilities Numbers are in millions	42.229	45.751	45.701	45.682	33.214	33.255	25.868	6.086	6.108	2.24	2.442	2.64	2.829	3.013	3.194	1.287	1.263	111.803	0	77.927	0
Total Liabilities Numbers are in millions	60.573	61.292	58.107	60.368	45.489	45.336	38.449	20.801	19.241	12.813	14.702	14.273	11.772	9.985	10.026	11.26	11.077	118.53	4.909	81.163	0
Equity:
Preferred Stock Numbers are in millions	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	178.993	44.657	77.927	77.927	55.029
Common Stock Numbers are in millions	0.006	0.006	0.006	0.006	0.006	0.005	0.004	0.004	0.004	0.004	0.002	0.002	0.002	0.002	0.002	0.002	0.002	0	0.001	0	0
Retained Earnings Numbers are in millions	-360.88	-336.31	-309.277	-285.93	-264.386	-247.748	-232.165	-214.761	-196.217	-179.845	-164.584	-147.7	-128.946	-114.666	-102.126	-91.076	-79.958	-51.863	-60.149	-34.652	0
Accumulated Other Comprehensive Income/Loss Numbers are in millions	0.186	-0.103	-0.105	0.041	-0.078	0.051	-0.036	-0.205	-0.477	-0.397	-0.129	0.018	0.003	0.018	0.012	0.002	-178.993	0.013	0.028	0.005	-13.875
Other Total Stockholders Equity Numbers are in millions	443.476	430.827	428.212	426.362	424.671	353.285	335.544	333.356	331.47	329.414	258.94	256.948	254.915	252.92	251.001	249.175	426.865	1.831	37.079	-76.499	0
Total Shareholders Equity Numbers are in millions	82.788	94.42	118.836	140.479	160.213	105.593	103.379	118.394	134.78	149.176	94.229	109.268	125.974	138.274	148.889	158.103	167.916	-50.019	70.827	-33.219	41.154
Total Equity Numbers are in millions	82.788	94.42	118.836	140.479	160.213	105.593	103.379	118.394	134.78	149.176	94.229	109.268	125.974	138.274	148.889	158.103	167.916	-50.019	70.827	-33.219	41.154
Total Liabilities & Shareholders Equity Numbers are in millions	143.361	155.712	176.943	200.847	205.702	150.929	141.828	139.195	154.021	161.989	108.931	123.541	137.746	148.259	158.915	169.363	178.993	68.511	75.736	47.944	41.154

Inozyme Pharma, Inc.

NASDAQ:INZY Add to watchlist

NASDAQ:INZY